Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIITerminatedMar 21, 2018Lupin Hydrocodone Bitartrate and Homatropine Methylbromide TabletsFailed Impurities/Degradation SpecificationsNovel Laboratories, Inc. · D-0599-2018Class IIITerminatedMar 21, 2018Clocortolone Pivalate CreamFailed Stability Specifications:Out-of-specification results observed for viscosity during stability testing.Dr. Reddy's Laboratories, Inc. · D-0598-2018Class ITerminatedMar 21, 2018HydromorphoneNon-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.Pfizer Inc. · D-0597-2018Class ITerminatedMar 21, 2018HydromorphoneNon-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.Pfizer Inc. · D-0596-2018Class IITerminatedMar 21, 2018Sermorelin AcetateStability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.American Pharmaceutical Ingredients LLC · D-0592-2018Class IITerminatedMar 21, 2018Oxytocin USPStability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.American Pharmaceutical Ingredients LLC · D-0591-2018Class IIITerminatedMar 21, 2018Psoriasin Daytime Relief Cream with Vitamin D & OatmealSubpotent Drug: The product has failed to maintain its label claim of coal tar throughout its labeled 24-month expiry period.Alva-Amco Pharmacal Companies., Inc. · D-0589-2018Class IITerminatedMar 21, 2018methylPREDNISolone Sodium Succinate for InjectionFailed Impurities/Degradation Specifications: High out of specification results for an impurity.Sagent Pharmaceuticals Inc · D-0588-2018Class IITerminatedMar 21, 2018methylPREDNISolone Sodium Succinate for InjectionFailed Impurities/Degradation Specifications: High out of specification results for an impurity.Sagent Pharmaceuticals Inc · D-0587-2018Class IITerminatedMar 21, 2018methylPREDNISolone Sodium Succinate for InjectionFailed Impurities/Degradation Specifications: High out of specification results for an impurity.Sagent Pharmaceuticals Inc · D-0586-2018Class IITerminatedMar 14, 2018RANITIDINE TabletsFailed Stability SpecificationsMckesson Packaging Services · D-0914-2018Class IIITerminatedMar 14, 2018labetalol HCl injection 20 mg/4 mLLabeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019...SCA Pharmaceuticals, LLC. · D-0603-2018Class ITerminatedMar 14, 2018Bella CapsulesMarketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was...Bella All Natural · D-0593-2018Class IITerminatedMar 14, 2018Coppertone Kids Sunscreen SprayLabeling: Label mix-upBayer HealthCare Pharmaceuticals, Inc. · D-0590-2018Class IIITerminatedMar 14, 2018LynparzaFailed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).AstraZeneca Pharmaceuticals LP · D-0585-2018Class IIITerminatedMar 14, 2018Life Brand Clear Action Acne Treatment Concealer StickSuperpotent drug: failed assay throughout the stick after 6 months stability.Oxygen Development Llc · D-0584-2018Class IITerminatedMar 14, 2018Ibuprofen Tablets USPCGMP deviations: Ibuprofen is being recalled in response to previous recallSpirit Pharmaceuticals, LLC · D-0583-2018Class IITerminatedMar 14, 2018Vardenafil HClcGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.Kalchem International, Inc. · D-0582-2018Class IIITerminatedMar 14, 2018Methylphenidate Hydrochloride Extended-release TabletsSubpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.Osmotica Pharmaceutical Corp · D-0581-2018Class IITerminatedMar 14, 2018Vancomycin 1.25g added to 250mL of 0.9% Sodium Chloride IV bagStability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.Apollo Care · D-0580-2018Class IITerminatedMar 14, 2018Vancomycin 1g added to 250mL of 0.9% Sodium Chloride IV bagStability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.Apollo Care · D-0579-2018Class IIITerminatedMar 14, 2018Atropine Sulfate Ophthalmic 1% SolutionFailed Stability Specification: OOS low viscosity results discovered during retain testing.Akorn, Inc. · D-0577-2018Class IITerminatedMar 14, 2018Labetalol Hydrochloride InjectionDefective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.Hospira Inc. A Pfizer Company · D-0576-2018Class ITerminatedMar 7, 2018Levofloxacin in 5% Dextrose InjectionPresence of Particulate Matter; contains visible particulate matter identified as mold.AuroMedics Pharma LLC · D-0574-2018Class ITerminatedMar 7, 2018GERICARE EyewashNon-sterility: confirmed microbial contamination with Achromobacter xylosoxidansKareway Products Inc · D-0551-2018Class IIITerminatedMar 7, 2018CystaranSubpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.Leadiant Biosciences, Inc · D-0550-2018Class IITerminatedMar 7, 20180.9% Sodium Chloride Irrigation USPPresence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to...B. Braun Medical Inc · D-0549-2018Class IITerminatedMar 7, 2018SyrSpend SF Suspending BaseMicrobial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).Fagron, Inc · D-0547-2018Class IITerminatedMar 7, 2018PVP Scrub SolutionSubpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.Medline Industries Inc · D-0546-2018Class IITerminatedMar 7, 2018INFeD (Iron Dextran Injection USP) 100 mg elemental iron/2 mlFailed Stability Specifications: Product stability testing results did not meet specifications for iron content.Allergan · D-0545-2018Class IITerminatedMar 7, 2018Acyclovir TabletsPresence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.Apace KY LLC · D-0544-2018Class IITerminatedFeb 28, 2018Fluticasone propionate USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0539-2018Class IITerminatedFeb 28, 2018Cyanocobalamin USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0538-2018Class IITerminatedFeb 28, 2018MethylcobalaminCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0537-2018Class IITerminatedFeb 28, 2018Biotin USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0536-2018Class IITerminatedFeb 28, 2018Ascorbic Acid USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0535-2018Class IITerminatedFeb 28, 2018Verapamil HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0534-2018Class IITerminatedFeb 28, 2018Vardenafil HCl USPCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0533-2018Class IITerminatedFeb 28, 2018Vancomycin HCl USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0532-2018Class IITerminatedFeb 28, 2018Ursodiol USP for prescription compoundingCGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.American Pharmaceutical Ingredients LLC · D-0531-2018